Last night, PDL BioPharma, Inc. (Nasdaq: PDLI) issued Q1 sales guidance of about $60 million, which compares to $50 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE